The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Covid-19 Treatment Market Research Report 2025
Synopsis
Patients today have more treatment options in the battle against coronavirus disease.
In November 2020, the FDA granted emergency use authorization to two monoclonal antibody treatments (bamlanivimab, made by Eli Lilly; and a combination of casirivimab and imdevimab, made by Regeneron). Both treatments have been approved for non-hospitalized adults and children over age 12 with mild to moderate COVID-19 symptoms who are at risk for developing severe COVID-19 or being hospitalized for it. In these patients, the approved treatments can reduce the risk of hospitalization and emergency room visits. These therapies must be given intravenously (by IV) soon after developing symptoms.
The FDA has approved the antiviral drug Veklury (remdesivir) for adults and certain pediatric patients with COVID-19 who are sick enough to need hospitalization. Veklury should only be administered in a hospital or in a health care setting capable of providing acute care comparable to inpatient hospital care.
The Drugs for Covid-19: Dexamethasone, Tocilizumab, Remdesivir, Baricitinib in combination with remdesivir, Anticoagulation drugs ("blood thinners"), etc.
In August 2020, the FDA issued an emergency use authorization (EUA) for convalescent plasma in patients hospitalized with COVID-19.
In this report, we study all treatment method for Covid-19.
The global Covid-19 Treatment market was valued at US$ 13910 million in 2023 and is anticipated to reach US$ 15 million by 2030, witnessing a CAGR of -59.3% during the forecast period 2024-2030.
Global core covid-19 treatment manufacturers include Cadila Healthcare, Novartis etc.The top 2 companies hold a share about 30%.North America is the largest market, with a share about 47%, followed by Europe and Asia Pacific with the share about 30% and 9%.
This report aims to provide a comprehensive presentation of the global market for Covid-19 Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Covid-19 Treatment.
Report Scope
The Covid-19 Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Covid-19 Treatment market comprehensively. Regional market sizes, concerning products by Type, by End User, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Covid-19 Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by End User, and by regions.
Market Segmentation
By Company
Cadila Healthcare
Johnson & Johnson
ImmunoPrecise
Novartis
AstraZeneca
Cipla
AbbVie
Bayer
Regeneron Pharmaceuticals
Ascletis Pharma
GlaxoSmithKline
Gilead Sciences
Pharmstandard
Fujifilm Holdings
Zhejiang Hisun Pharmaceutical Co. Ltd
Roche
Sanofi
Pfizer
Eli Lilly
Segment by Type
Life Support
Antiviral Medicine
Antibody Treatments
Others
Segment by End User
Children
Adult
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by End User, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Covid-19 Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by End User, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Patients today have more treatment options in the battle against coronavirus disease.
In November 2020, the FDA granted emergency use authorization to two monoclonal antibody treatments (bamlanivimab, made by Eli Lilly; and a combination of casirivimab and imdevimab, made by Regeneron). Both treatments have been approved for non-hospitalized adults and children over age 12 with mild to moderate COVID-19 symptoms who are at risk for developing severe COVID-19 or being hospitalized for it. In these patients, the approved treatments can reduce the risk of hospitalization and emergency room visits. These therapies must be given intravenously (by IV) soon after developing symptoms.
The FDA has approved the antiviral drug Veklury (remdesivir) for adults and certain pediatric patients with COVID-19 who are sick enough to need hospitalization. Veklury should only be administered in a hospital or in a health care setting capable of providing acute care comparable to inpatient hospital care.
The Drugs for Covid-19: Dexamethasone, Tocilizumab, Remdesivir, Baricitinib in combination with remdesivir, Anticoagulation drugs ("blood thinners"), etc.
In August 2020, the FDA issued an emergency use authorization (EUA) for convalescent plasma in patients hospitalized with COVID-19.
In this report, we study all treatment method for Covid-19.
The global Covid-19 Treatment market was valued at US$ 13910 million in 2023 and is anticipated to reach US$ 15 million by 2030, witnessing a CAGR of -59.3% during the forecast period 2024-2030.
Global core covid-19 treatment manufacturers include Cadila Healthcare, Novartis etc.The top 2 companies hold a share about 30%.North America is the largest market, with a share about 47%, followed by Europe and Asia Pacific with the share about 30% and 9%.
This report aims to provide a comprehensive presentation of the global market for Covid-19 Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Covid-19 Treatment.
Report Scope
The Covid-19 Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Covid-19 Treatment market comprehensively. Regional market sizes, concerning products by Type, by End User, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Covid-19 Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by End User, and by regions.
Market Segmentation
By Company
Cadila Healthcare
Johnson & Johnson
ImmunoPrecise
Novartis
AstraZeneca
Cipla
AbbVie
Bayer
Regeneron Pharmaceuticals
Ascletis Pharma
GlaxoSmithKline
Gilead Sciences
Pharmstandard
Fujifilm Holdings
Zhejiang Hisun Pharmaceutical Co. Ltd
Roche
Sanofi
Pfizer
Eli Lilly
Segment by Type
Life Support
Antiviral Medicine
Antibody Treatments
Others
Segment by End User
Children
Adult
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by End User, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Covid-19 Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by End User, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Covid-19 Treatment Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Life Support
1.2.3 Antiviral Medicine
1.2.4 Antibody Treatments
1.2.5 Others
1.3 Market by End User
1.3.1 Global Covid-19 Treatment Market Growth by End User: 2019 VS 2023 VS 2030
1.3.2 Children
1.3.3 Adult
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Covid-19 Treatment Market Perspective (2019-2030)
2.2 Covid-19 Treatment Growth Trends by Region
2.2.1 Global Covid-19 Treatment Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Covid-19 Treatment Historic Market Size by Region (2019-2024)
2.2.3 Covid-19 Treatment Forecasted Market Size by Region (2025-2030)
2.3 Covid-19 Treatment Market Dynamics
2.3.1 Covid-19 Treatment Industry Trends
2.3.2 Covid-19 Treatment Market Drivers
2.3.3 Covid-19 Treatment Market Challenges
2.3.4 Covid-19 Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Covid-19 Treatment Players by Revenue
3.1.1 Global Top Covid-19 Treatment Players by Revenue (2019-2024)
3.1.2 Global Covid-19 Treatment Revenue Market Share by Players (2019-2024)
3.2 Global Covid-19 Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Covid-19 Treatment Revenue
3.4 Global Covid-19 Treatment Market Concentration Ratio
3.4.1 Global Covid-19 Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Covid-19 Treatment Revenue in 2023
3.5 Covid-19 Treatment Key Players Head office and Area Served
3.6 Key Players Covid-19 Treatment Product Solution and Service
3.7 Date of Enter into Covid-19 Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Covid-19 Treatment Breakdown Data by Type
4.1 Global Covid-19 Treatment Historic Market Size by Type (2019-2024)
4.2 Global Covid-19 Treatment Forecasted Market Size by Type (2025-2030)
5 Covid-19 Treatment Breakdown Data by End User
5.1 Global Covid-19 Treatment Historic Market Size by End User (2019-2024)
5.2 Global Covid-19 Treatment Forecasted Market Size by End User (2025-2030)
6 North America
6.1 North America Covid-19 Treatment Market Size (2019-2030)
6.2 North America Covid-19 Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Covid-19 Treatment Market Size by Country (2019-2024)
6.4 North America Covid-19 Treatment Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Covid-19 Treatment Market Size (2019-2030)
7.2 Europe Covid-19 Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Covid-19 Treatment Market Size by Country (2019-2024)
7.4 Europe Covid-19 Treatment Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Covid-19 Treatment Market Size (2019-2030)
8.2 Asia-Pacific Covid-19 Treatment Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Covid-19 Treatment Market Size by Region (2019-2024)
8.4 Asia-Pacific Covid-19 Treatment Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Covid-19 Treatment Market Size (2019-2030)
9.2 Latin America Covid-19 Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Covid-19 Treatment Market Size by Country (2019-2024)
9.4 Latin America Covid-19 Treatment Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Covid-19 Treatment Market Size (2019-2030)
10.2 Middle East & Africa Covid-19 Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Covid-19 Treatment Market Size by Country (2019-2024)
10.4 Middle East & Africa Covid-19 Treatment Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Cadila Healthcare
11.1.1 Cadila Healthcare Company Detail
11.1.2 Cadila Healthcare Business Overview
11.1.3 Cadila Healthcare Covid-19 Treatment Introduction
11.1.4 Cadila Healthcare Revenue in Covid-19 Treatment Business (2019-2024)
11.1.5 Cadila Healthcare Recent Development
11.2 Johnson & Johnson
11.2.1 Johnson & Johnson Company Detail
11.2.2 Johnson & Johnson Business Overview
11.2.3 Johnson & Johnson Covid-19 Treatment Introduction
11.2.4 Johnson & Johnson Revenue in Covid-19 Treatment Business (2019-2024)
11.2.5 Johnson & Johnson Recent Development
11.3 ImmunoPrecise
11.3.1 ImmunoPrecise Company Detail
11.3.2 ImmunoPrecise Business Overview
11.3.3 ImmunoPrecise Covid-19 Treatment Introduction
11.3.4 ImmunoPrecise Revenue in Covid-19 Treatment Business (2019-2024)
11.3.5 ImmunoPrecise Recent Development
11.4 Novartis
11.4.1 Novartis Company Detail
11.4.2 Novartis Business Overview
11.4.3 Novartis Covid-19 Treatment Introduction
11.4.4 Novartis Revenue in Covid-19 Treatment Business (2019-2024)
11.4.5 Novartis Recent Development
11.5 AstraZeneca
11.5.1 AstraZeneca Company Detail
11.5.2 AstraZeneca Business Overview
11.5.3 AstraZeneca Covid-19 Treatment Introduction
11.5.4 AstraZeneca Revenue in Covid-19 Treatment Business (2019-2024)
11.5.5 AstraZeneca Recent Development
11.6 Cipla
11.6.1 Cipla Company Detail
11.6.2 Cipla Business Overview
11.6.3 Cipla Covid-19 Treatment Introduction
11.6.4 Cipla Revenue in Covid-19 Treatment Business (2019-2024)
11.6.5 Cipla Recent Development
11.7 AbbVie
11.7.1 AbbVie Company Detail
11.7.2 AbbVie Business Overview
11.7.3 AbbVie Covid-19 Treatment Introduction
11.7.4 AbbVie Revenue in Covid-19 Treatment Business (2019-2024)
11.7.5 AbbVie Recent Development
11.8 Bayer
11.8.1 Bayer Company Detail
11.8.2 Bayer Business Overview
11.8.3 Bayer Covid-19 Treatment Introduction
11.8.4 Bayer Revenue in Covid-19 Treatment Business (2019-2024)
11.8.5 Bayer Recent Development
11.9 Regeneron Pharmaceuticals
11.9.1 Regeneron Pharmaceuticals Company Detail
11.9.2 Regeneron Pharmaceuticals Business Overview
11.9.3 Regeneron Pharmaceuticals Covid-19 Treatment Introduction
11.9.4 Regeneron Pharmaceuticals Revenue in Covid-19 Treatment Business (2019-2024)
11.9.5 Regeneron Pharmaceuticals Recent Development
11.10 Ascletis Pharma
11.10.1 Ascletis Pharma Company Detail
11.10.2 Ascletis Pharma Business Overview
11.10.3 Ascletis Pharma Covid-19 Treatment Introduction
11.10.4 Ascletis Pharma Revenue in Covid-19 Treatment Business (2019-2024)
11.10.5 Ascletis Pharma Recent Development
11.11 GlaxoSmithKline
11.11.1 GlaxoSmithKline Company Detail
11.11.2 GlaxoSmithKline Business Overview
11.11.3 GlaxoSmithKline Covid-19 Treatment Introduction
11.11.4 GlaxoSmithKline Revenue in Covid-19 Treatment Business (2019-2024)
11.11.5 GlaxoSmithKline Recent Development
11.12 Gilead Sciences
11.12.1 Gilead Sciences Company Detail
11.12.2 Gilead Sciences Business Overview
11.12.3 Gilead Sciences Covid-19 Treatment Introduction
11.12.4 Gilead Sciences Revenue in Covid-19 Treatment Business (2019-2024)
11.12.5 Gilead Sciences Recent Development
11.13 Pharmstandard
11.13.1 Pharmstandard Company Detail
11.13.2 Pharmstandard Business Overview
11.13.3 Pharmstandard Covid-19 Treatment Introduction
11.13.4 Pharmstandard Revenue in Covid-19 Treatment Business (2019-2024)
11.13.5 Pharmstandard Recent Development
11.14 Fujifilm Holdings
11.14.1 Fujifilm Holdings Company Detail
11.14.2 Fujifilm Holdings Business Overview
11.14.3 Fujifilm Holdings Covid-19 Treatment Introduction
11.14.4 Fujifilm Holdings Revenue in Covid-19 Treatment Business (2019-2024)
11.14.5 Fujifilm Holdings Recent Development
11.15 Zhejiang Hisun Pharmaceutical Co. Ltd
11.15.1 Zhejiang Hisun Pharmaceutical Co. Ltd Company Detail
11.15.2 Zhejiang Hisun Pharmaceutical Co. Ltd Business Overview
11.15.3 Zhejiang Hisun Pharmaceutical Co. Ltd Covid-19 Treatment Introduction
11.15.4 Zhejiang Hisun Pharmaceutical Co. Ltd Revenue in Covid-19 Treatment Business (2019-2024)
11.15.5 Zhejiang Hisun Pharmaceutical Co. Ltd Recent Development
11.16 Roche
11.16.1 Roche Company Detail
11.16.2 Roche Business Overview
11.16.3 Roche Covid-19 Treatment Introduction
11.16.4 Roche Revenue in Covid-19 Treatment Business (2019-2024)
11.16.5 Roche Recent Development
11.17 Sanofi
11.17.1 Sanofi Company Detail
11.17.2 Sanofi Business Overview
11.17.3 Sanofi Covid-19 Treatment Introduction
11.17.4 Sanofi Revenue in Covid-19 Treatment Business (2019-2024)
11.17.5 Sanofi Recent Development
11.18 Pfizer
11.18.1 Pfizer Company Detail
11.18.2 Pfizer Business Overview
11.18.3 Pfizer Covid-19 Treatment Introduction
11.18.4 Pfizer Revenue in Covid-19 Treatment Business (2019-2024)
11.18.5 Pfizer Recent Development
11.19 Eli Lilly
11.19.1 Eli Lilly Company Detail
11.19.2 Eli Lilly Business Overview
11.19.3 Eli Lilly Covid-19 Treatment Introduction
11.19.4 Eli Lilly Revenue in Covid-19 Treatment Business (2019-2024)
11.19.5 Eli Lilly Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Covid-19 Treatment Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Life Support
Table 3. Key Players of Antiviral Medicine
Table 4. Key Players of Antibody Treatments
Table 5. Key Players of Others
Table 6. Global Covid-19 Treatment Market Size Growth by End User (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Covid-19 Treatment Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Covid-19 Treatment Market Size by Region (2019-2024) & (US$ Million)
Table 9. Global Covid-19 Treatment Market Share by Region (2019-2024)
Table 10. Global Covid-19 Treatment Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 11. Global Covid-19 Treatment Market Share by Region (2025-2030)
Table 12. Covid-19 Treatment Market Trends
Table 13. Covid-19 Treatment Market Drivers
Table 14. Covid-19 Treatment Market Challenges
Table 15. Covid-19 Treatment Market Restraints
Table 16. Global Covid-19 Treatment Revenue by Players (2019-2024) & (US$ Million)
Table 17. Global Covid-19 Treatment Market Share by Players (2019-2024)
Table 18. Global Top Covid-19 Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Covid-19 Treatment as of 2023)
Table 19. Ranking of Global Top Covid-19 Treatment Companies by Revenue (US$ Million) in 2023
Table 20. Global 5 Largest Players Market Share by Covid-19 Treatment Revenue (CR5 and HHI) & (2019-2024)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Covid-19 Treatment Product Solution and Service
Table 23. Date of Enter into Covid-19 Treatment Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Covid-19 Treatment Market Size by Type (2019-2024) & (US$ Million)
Table 26. Global Covid-19 Treatment Revenue Market Share by Type (2019-2024)
Table 27. Global Covid-19 Treatment Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 28. Global Covid-19 Treatment Revenue Market Share by Type (2025-2030)
Table 29. Global Covid-19 Treatment Market Size by End User (2019-2024) & (US$ Million)
Table 30. Global Covid-19 Treatment Revenue Market Share by End User (2019-2024)
Table 31. Global Covid-19 Treatment Forecasted Market Size by End User (2025-2030) & (US$ Million)
Table 32. Global Covid-19 Treatment Revenue Market Share by End User (2025-2030)
Table 33. North America Covid-19 Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 34. North America Covid-19 Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 35. North America Covid-19 Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 36. Europe Covid-19 Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 37. Europe Covid-19 Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 38. Europe Covid-19 Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 39. Asia-Pacific Covid-19 Treatment Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 40. Asia-Pacific Covid-19 Treatment Market Size by Region (2019-2024) & (US$ Million)
Table 41. Asia-Pacific Covid-19 Treatment Market Size by Region (2025-2030) & (US$ Million)
Table 42. Latin America Covid-19 Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 43. Latin America Covid-19 Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 44. Latin America Covid-19 Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Covid-19 Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 46. Middle East & Africa Covid-19 Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 47. Middle East & Africa Covid-19 Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 48. Cadila Healthcare Company Detail
Table 49. Cadila Healthcare Business Overview
Table 50. Cadila Healthcare Covid-19 Treatment Product
Table 51. Cadila Healthcare Revenue in Covid-19 Treatment Business (2019-2024) & (US$ Million)
Table 52. Cadila Healthcare Recent Development
Table 53. Johnson & Johnson Company Detail
Table 54. Johnson & Johnson Business Overview
Table 55. Johnson & Johnson Covid-19 Treatment Product
Table 56. Johnson & Johnson Revenue in Covid-19 Treatment Business (2019-2024) & (US$ Million)
Table 57. Johnson & Johnson Recent Development
Table 58. ImmunoPrecise Company Detail
Table 59. ImmunoPrecise Business Overview
Table 60. ImmunoPrecise Covid-19 Treatment Product
Table 61. ImmunoPrecise Revenue in Covid-19 Treatment Business (2019-2024) & (US$ Million)
Table 62. ImmunoPrecise Recent Development
Table 63. Novartis Company Detail
Table 64. Novartis Business Overview
Table 65. Novartis Covid-19 Treatment Product
Table 66. Novartis Revenue in Covid-19 Treatment Business (2019-2024) & (US$ Million)
Table 67. Novartis Recent Development
Table 68. AstraZeneca Company Detail
Table 69. AstraZeneca Business Overview
Table 70. AstraZeneca Covid-19 Treatment Product
Table 71. AstraZeneca Revenue in Covid-19 Treatment Business (2019-2024) & (US$ Million)
Table 72. AstraZeneca Recent Development
Table 73. Cipla Company Detail
Table 74. Cipla Business Overview
Table 75. Cipla Covid-19 Treatment Product
Table 76. Cipla Revenue in Covid-19 Treatment Business (2019-2024) & (US$ Million)
Table 77. Cipla Recent Development
Table 78. AbbVie Company Detail
Table 79. AbbVie Business Overview
Table 80. AbbVie Covid-19 Treatment Product
Table 81. AbbVie Revenue in Covid-19 Treatment Business (2019-2024) & (US$ Million)
Table 82. AbbVie Recent Development
Table 83. Bayer Company Detail
Table 84. Bayer Business Overview
Table 85. Bayer Covid-19 Treatment Product
Table 86. Bayer Revenue in Covid-19 Treatment Business (2019-2024) & (US$ Million)
Table 87. Bayer Recent Development
Table 88. Regeneron Pharmaceuticals Company Detail
Table 89. Regeneron Pharmaceuticals Business Overview
Table 90. Regeneron Pharmaceuticals Covid-19 Treatment Product
Table 91. Regeneron Pharmaceuticals Revenue in Covid-19 Treatment Business (2019-2024) & (US$ Million)
Table 92. Regeneron Pharmaceuticals Recent Development
Table 93. Ascletis Pharma Company Detail
Table 94. Ascletis Pharma Business Overview
Table 95. Ascletis Pharma Covid-19 Treatment Product
Table 96. Ascletis Pharma Revenue in Covid-19 Treatment Business (2019-2024) & (US$ Million)
Table 97. Ascletis Pharma Recent Development
Table 98. GlaxoSmithKline Company Detail
Table 99. GlaxoSmithKline Business Overview
Table 100. GlaxoSmithKline Covid-19 Treatment Product
Table 101. GlaxoSmithKline Revenue in Covid-19 Treatment Business (2019-2024) & (US$ Million)
Table 102. GlaxoSmithKline Recent Development
Table 103. Gilead Sciences Company Detail
Table 104. Gilead Sciences Business Overview
Table 105. Gilead Sciences Covid-19 Treatment Product
Table 106. Gilead Sciences Revenue in Covid-19 Treatment Business (2019-2024) & (US$ Million)
Table 107. Gilead Sciences Recent Development
Table 108. Pharmstandard Company Detail
Table 109. Pharmstandard Business Overview
Table 110. Pharmstandard Covid-19 Treatment Product
Table 111. Pharmstandard Revenue in Covid-19 Treatment Business (2019-2024) & (US$ Million)
Table 112. Pharmstandard Recent Development
Table 113. Fujifilm Holdings Company Detail
Table 114. Fujifilm Holdings Business Overview
Table 115. Fujifilm Holdings Covid-19 Treatment Product
Table 116. Fujifilm Holdings Revenue in Covid-19 Treatment Business (2019-2024) & (US$ Million)
Table 117. Fujifilm Holdings Recent Development
Table 118. Zhejiang Hisun Pharmaceutical Co. Ltd Company Detail
Table 119. Zhejiang Hisun Pharmaceutical Co. Ltd Business Overview
Table 120. Zhejiang Hisun Pharmaceutical Co. Ltd Covid-19 Treatment Product
Table 121. Zhejiang Hisun Pharmaceutical Co. Ltd Revenue in Covid-19 Treatment Business (2019-2024) & (US$ Million)
Table 122. Zhejiang Hisun Pharmaceutical Co. Ltd Recent Development
Table 123. Roche Company Detail
Table 124. Roche Business Overview
Table 125. Roche Covid-19 Treatment Product
Table 126. Roche Revenue in Covid-19 Treatment Business (2019-2024) & (US$ Million)
Table 127. Roche Recent Development
Table 128. Sanofi Company Detail
Table 129. Sanofi Business Overview
Table 130. Sanofi Covid-19 Treatment Product
Table 131. Sanofi Revenue in Covid-19 Treatment Business (2019-2024) & (US$ Million)
Table 132. Sanofi Recent Development
Table 133. Pfizer Company Detail
Table 134. Pfizer Business Overview
Table 135. Pfizer Covid-19 Treatment Product
Table 136. Pfizer Revenue in Covid-19 Treatment Business (2019-2024) & (US$ Million)
Table 137. Pfizer Recent Development
Table 138. Eli Lilly Company Detail
Table 139. Eli Lilly Business Overview
Table 140. Eli Lilly Covid-19 Treatment Product
Table 141. Eli Lilly Revenue in Covid-19 Treatment Business (2019-2024) & (US$ Million)
Table 142. Eli Lilly Recent Development
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Covid-19 Treatment Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Covid-19 Treatment Market Share by Type: 2023 VS 2030
Figure 3. Life Support Features
Figure 4. Antiviral Medicine Features
Figure 5. Antibody Treatments Features
Figure 6. Others Features
Figure 7. Global Covid-19 Treatment Market Size Comparison by End User (2024-2030) & (US$ Million)
Figure 8. Global Covid-19 Treatment Market Share by End User: 2023 VS 2030
Figure 9. Children Case Studies
Figure 10. Adult Case Studies
Figure 11. Covid-19 Treatment Report Years Considered
Figure 12. Global Covid-19 Treatment Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 13. Global Covid-19 Treatment Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Covid-19 Treatment Market Share by Region: 2023 VS 2030
Figure 15. Global Covid-19 Treatment Market Share by Players in 2023
Figure 16. Global Top Covid-19 Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Covid-19 Treatment as of 2023)
Figure 17. The Top 10 and 5 Players Market Share by Covid-19 Treatment Revenue in 2023
Figure 18. North America Covid-19 Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. North America Covid-19 Treatment Market Share by Country (2019-2030)
Figure 20. United States Covid-19 Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Canada Covid-19 Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Covid-19 Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Covid-19 Treatment Market Share by Country (2019-2030)
Figure 24. Germany Covid-19 Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. France Covid-19 Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. U.K. Covid-19 Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Italy Covid-19 Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Russia Covid-19 Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Nordic Countries Covid-19 Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Covid-19 Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Covid-19 Treatment Market Share by Region (2019-2030)
Figure 32. China Covid-19 Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Japan Covid-19 Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. South Korea Covid-19 Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Southeast Asia Covid-19 Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. India Covid-19 Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Australia Covid-19 Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Covid-19 Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Covid-19 Treatment Market Share by Country (2019-2030)
Figure 40. Mexico Covid-19 Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Brazil Covid-19 Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Covid-19 Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Covid-19 Treatment Market Share by Country (2019-2030)
Figure 44. Turkey Covid-19 Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Saudi Arabia Covid-19 Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Cadila Healthcare Revenue Growth Rate in Covid-19 Treatment Business (2019-2024)
Figure 47. Johnson & Johnson Revenue Growth Rate in Covid-19 Treatment Business (2019-2024)
Figure 48. ImmunoPrecise Revenue Growth Rate in Covid-19 Treatment Business (2019-2024)
Figure 49. Novartis Revenue Growth Rate in Covid-19 Treatment Business (2019-2024)
Figure 50. AstraZeneca Revenue Growth Rate in Covid-19 Treatment Business (2019-2024)
Figure 51. Cipla Revenue Growth Rate in Covid-19 Treatment Business (2019-2024)
Figure 52. AbbVie Revenue Growth Rate in Covid-19 Treatment Business (2019-2024)
Figure 53. Bayer Revenue Growth Rate in Covid-19 Treatment Business (2019-2024)
Figure 54. Regeneron Pharmaceuticals Revenue Growth Rate in Covid-19 Treatment Business (2019-2024)
Figure 55. Ascletis Pharma Revenue Growth Rate in Covid-19 Treatment Business (2019-2024)
Figure 56. GlaxoSmithKline Revenue Growth Rate in Covid-19 Treatment Business (2019-2024)
Figure 57. Gilead Sciences Revenue Growth Rate in Covid-19 Treatment Business (2019-2024)
Figure 58. Pharmstandard Revenue Growth Rate in Covid-19 Treatment Business (2019-2024)
Figure 59. Fujifilm Holdings Revenue Growth Rate in Covid-19 Treatment Business (2019-2024)
Figure 60. Zhejiang Hisun Pharmaceutical Co. Ltd Revenue Growth Rate in Covid-19 Treatment Business (2019-2024)
Figure 61. Roche Revenue Growth Rate in Covid-19 Treatment Business (2019-2024)
Figure 62. Sanofi Revenue Growth Rate in Covid-19 Treatment Business (2019-2024)
Figure 63. Pfizer Revenue Growth Rate in Covid-19 Treatment Business (2019-2024)
Figure 64. Eli Lilly Revenue Growth Rate in Covid-19 Treatment Business (2019-2024)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
